Skip to content
healthcare.dev

Azacitidine

NDC 43817-906, Azacitidine, injection, powder, lyophilized, for solution, from Panacea Biotec Limited.

Product NDC
43817-906
Status
Listed
Labeler
Panacea Biotec Limited
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207234
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43817-906 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/50mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
43817-906-01438170906011 VIAL, SINGLE-DOSE in 1 CARTON (43817-906-01) / 50 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9abb489d-ce54-4140-83f6-b756f00b0967

Use it

Look up 43817-906 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43817-906 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43817-906. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.